PA
SANA icon

Profund Advisors’s Sana Biotechnology SANA Stock Holding History

Profund Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$453K Buy
157,122
+55,076
+54% +$217K 0.02% 586
2025
Q4 		$415K Buy
102,046
+44,326
+77% +$198K 0.01% 651
2025
Q3 		$205K Buy
+57,720
New +$209K 0.01% 969
2025
Q2 		– Sell
-41,082
Closed -$69K – 1039
2025
Q1 		$69K Sell
41,082
-19,494
-32% -$54.5K ﹤0.01% 972
2024
Q4 		$98.7K Sell
60,576
-3,575
-6% -$10.7K ﹤0.01% 1072
2024
Q3 		$267K Buy
64,151
+1,068
+2% +$5.61K 0.01% 868
2024
Q2 		$344K Sell
63,083
-14,119
-18% -$113K 0.01% 642
2024
Q1 		$772K Buy
77,202
+6,499
+9% +$48.7K 0.03% 429
2023
Q4 		$288K Buy
70,703
+15,389
+28% +$56.7K 0.01% 798
2023
Q3 		$214K Sell
55,314
-6,163
-10% -$33.1K 0.01% 845
2023
Q2 		$366K Sell
61,477
-14,466
-19% -$83.4K 0.02% 617
2023
Q1 		$248K Buy
+75,943
New +$303K 0.02% 838

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Profund Advisors's SANA Position: Q1 2026 in Review

Profund Advisors increased its Sana Biotechnology (SANA) stake by 54% in Q1 2026, buying an estimated $217K and bringing the position to 157,122 shares worth $453K. The position accounts for 0.02% of the portfolio, ranked #586.

Profund Advisors first reported a position in SANA in Q1 2023 and has held it in 12 quarters since. The position peaked at $772K in Q1 2024. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Profund Advisors held 157,122 shares of Sana Biotechnology worth $453K as of Q1 2026.
  • Profund Advisors bought 55,076 Sana Biotechnology shares in Q1 2026, an estimated $217K.
  • Sana Biotechnology made up 0.02% of Profund Advisors's portfolio in Q1 2026, its #586 holding.
  • Profund Advisors first reported a position in Sana Biotechnology in Q1 2023 and has held it in 12 quarters since.
  • Profund Advisors's Sana Biotechnology position peaked at $772K in Q1 2024.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.